Maya Zlatanova

What Stops Patient Engagement in Clinical Trials

Last week I was invited to speak at Bayer’s Headquarters during their Annual Patient Engagement Meetup. This year I was attending a lot of other similar events thanks to our collaboration with different companies like Boehringer Ingelheim, Merck, Novartis, etc. And the last one really reminded me of: What Stops Patient Engagement in Clinical Research? …

What Stops Patient Engagement in Clinical Trials Read More »

We interviewed 50+ feasibility experts about their best practices

Since the launch of our feasibility and patient intelligence platform TrialHub, my team and I have spent hundreds of hours with feasibility teams worldwide to understand how they structure their processes and to make them more scalable and time-saving. I feel blessed I have been able to work with world-class experts trying to solve clinical …

We interviewed 50+ feasibility experts about their best practices Read More »

Patients and Clinical Trials: TRUST is what we need the most

The past few months were a challenge for everyone. Yet, the fear that patients felt due to the COVID-19 treat is indescribable. The high-risk patients were faced with multiple dilemmas like: Should I go and see my doctor for a regular check-up? How am I supposed to get my medicines prescribed? My parents are both …

Patients and Clinical Trials: TRUST is what we need the most Read More »

3 Factors CROs Consider Sponsors Rarely Think Of

Clinical Research Organizations (CRO) are the go-to partner for helping biotech and pharma companies to research, evaluate and launch their new brilliant idea of a novel compound or medical device. And in fact, the CRO market has been growing in the last few years and is expected to reach $44bln by 2021. You can see …

3 Factors CROs Consider Sponsors Rarely Think Of Read More »

Data sources in Feasibility for clinical trials | Part 2

In my last article about Feasibility, data sources are defined so that you can recognise the best ones and choose which ones to use. To summarise, no matter what data sources you use they should be: Accurate Meaningful All-encompassing   If you want to learn more about this, you can read my previous article: Today …

Data sources in Feasibility for clinical trials | Part 2 Read More »

Data sources in Feasibility for clinical trials? | Part 1

Feasibility for clinical trials is all about finding the right sources of data, being able to analyse them and then make decisions for country selection, sites and investigators, as well as patient recruitment strategies. It sounds simple and yet, when it comes to execution it’s very complicated. Therefore feasibility specialists have a lot of questions …

Data sources in Feasibility for clinical trials? | Part 1 Read More »

How to measure patient enrollment (on budget and on time)

There are many questions when planning a clinical trial. But one of those questions is the main one: How many patients can we enroll? And the answer is everything but straightforward or easy to provide. Yet, answering this one question could mean the world to a biotech startup that just raised its funding and gives …

How to measure patient enrollment (on budget and on time) Read More »

Global Clinical Operations Director’s insights from 2008 and top lessons that apply during COVID-19

Estrella Garcia is with Almirall for 27 years and is currently their Global Clinical Operations Director. She was with the pharma company during the last financial crisis and went through some really hard times for the company. She shares with Maya Zlatanova, CEO of FindMeCure Ltd., the lessons she learned and that helped them not …

Global Clinical Operations Director’s insights from 2008 and top lessons that apply during COVID-19 Read More »